Navigation Links
Pneumonia Vaccine Effective Among Children

The pneumococcal vaccine was introduced in 2000 and was later recommendation for all children 2 to 23 months old. This has led to a decrease in the rates of pneumonia among young infants. //Studies suggest that the drop in pneumococcal disease among children younger than 2 years of age was due to immunization rather than the vaccine.

This is because infants who were too young to receive the vaccine also showed a reduce in the infection rate. But in the present study that was conducted by Dr. Katherine A. Poehling, from Vanderbilt University School of Medicine in Nashville, and colleagues it showed something different. She assessed the pneumonia rates among infants, 0 to 90 days of age, before and after the introduction of the pneumonia vaccine.

In the eight states studied, 89 cases of invasive pneumococcal disease occurred before introduction and 57 occurred after introduction of the vaccine. With the introduction of the vaccine, the average rate of pneumococcal disease among young infants fell 40 %. The reduction was most pronounced for black infants. In case of white infants the decline was not statistically significant.

In conclusion the authors says that the pneumonia vaccine has resulted in herd immunity because neonates and young infants have had a significant decrease in pneumococcal disease rates, although they are too young to receive a full series of the vaccine.


'"/>




Page: 1

Related medicine news :

1. Toxin connected to Flesh-eating Pneumonia in Kids
2. A new Vaccine for Pneumonia
3. The After Effects Of Pneumonia
4. Acid Suppressive Drugs Found To Increase The Risk for Pneumonia
5. Tsunami Survivors Face Pneumonia Threat
6. New Vaccine Found To Be Effective In Reducing Childhood Pneumonia
7. Zinc Effective In Helping Kids Recover From Pneumonia
8. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
9. Pneumonia Claims 30 Lives In Pakistan
10. Pneumonia Effectively Treated with Short-Term Antibiotic Course
11. Five Tribal Children Succumbs to Pneumonia in Orissa
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... 25, 2017 , ... FDAnews Expert Insight Series:, Device Regulation ... – 3:00 p.m. ET, http://www.fdanews.com/deviceregulation      , FDA Commissioner Scott ... short months:, ,     The first device recall over cybersecurity (a ...
(Date:9/25/2017)... ... September 25, 2017 , ... Introducing Panther, the revolutionary new iPhone case ... platform Kickstarter seeking support for the #WarOnGrime. , Fact: iPhones are 18 ... shockingly revolting, yet true. The Panther iPhone cases are the first weapon in the ...
(Date:9/25/2017)... ... September 25, 2017 , ... How many things are on ... includes the phrase “more than any sane human could possibly complete,” then you’re all ... think, and are desperately trying to be everything to everybody all the time. , ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... quality and efficiency. The principle of First-Defect-Stop for laboratory weighing is ... they have the chance to have negative consequences on downstream processes. , If ...
(Date:9/25/2017)... FL (PRWEB) , ... September 25, 2017 , ... Physician ... Richey, Fla. location at 5304 Main Street as an interventional pain management specialist. ... spine and extremities. He joins PPOA from private practice In Brooksville, Fla. His orthopedic ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
(Date:9/12/2017)... MOUNTAIN LAKES, N.J. , Sept. 12, 2017  Consumer reviews ... Embrace Hearing as the number one company for hearing ... Oticon™, ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology: